| Literature DB >> 29566093 |
Sergei Voloshin1, Olga Smoldovskaya1, Guzel Feyzkhanova1, Alla Arefieva1, Lyudmila Pavlushkina2, Tatiana Filatova2, Veronika Butvilovskaya1, Marina Filippova1, Yuri Lysov1, Sergey Shcherbo2, Alexander Makarov1, Alla Rubina1, Alexander Zasedatelev1.
Abstract
The immunological profiles of human specific IgE (sIgE) and specific IgG4 (sIgG4) vary by genetic predisposition, living conditions in different geographical locations and patient's age. The aim of our study was to analyze sIgE and sIgG4 patterns and their age-dependent changes in patients from the Moscow region. For identifying sIgE and sIgG4 profiles the blood samples from 513 patients aged 6 months to 17 years who were showing symptoms of allergic diseases were analyzed using microarrays containing 31 allergens. The highest sIgE prevalence was observed for birch pollen (32%) among pollen allergens, cat dander (24%) among indoor allergens, and egg whites (21%) among food allergens. The most common sIgG4 response was developed toward egg whites (80% of patients). Age-related elevation was identified for patients with increased sIgE to pollen allergens and indoor allergens (cat or dog dander and house dust mites). For each allergen, the proportion of cases with significant levels of sIgG4 appeared to increase with patients' age. The data on allergen-specific sIgE and sIgG4 prevalence show both general trends and some local special aspects that are indicative for the Moscow region. This information should be useful in terms of epidemiology of allergic diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29566093 PMCID: PMC5864043 DOI: 10.1371/journal.pone.0194775
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The number and percent of samples from patients with or without increased levels of sIgE (cut-off at 0.35 IU/ml) or significant levels of sIgG4 (cut-off at 110 ng/ml) to at least one allergen depending on age and gender (total sample size N = 513).
| Groups, ages | Total | Male | Female | Male | Female | ||||
|---|---|---|---|---|---|---|---|---|---|
| sIgE | sIgE | sIgE | sIgE | sIgG4 | sIgG4 | sIgG4 | sIgG4 | ||
| ≥ 0.35 IU/ml | < 0.35 IU/ml | ≥ 0.35 IU/ml | < 0.35 IU/ml | ≥ 110 ng/ml | < 110 ng/ml | ≥ 110 ng/ml | < 110 ng/ml | ||
| 13 (16%) | 26 (32%) | 20 (25%) | 22 (27%) | 26 (32%) | 13 (16%) | 21 (26%) | 21 (26%) | ||
| 27 (30%) | 21 (23%) | 28 (31%) | 14 (16%) | 43 (48%) | 5 (6%) | 38 (42%) | 4 (4%) | ||
| 27 (35%) | 16 (21%) | 19 (25%) | 15 (19%) | 42 (54%) | 1 (1%) | 32 (42%) | 2 (3%) | ||
| 42 (49%) | 16 (19%) | 18 (21%) | 9 (11%) | 56 (66%) | 2 (2%) | 25 (30%) | 2 (2%) | ||
| 32 (34%) | 19 (20%) | 30 (32%) | 13 (14%) | 47 (50%) | 4 (4%) | 42 (45%) | 1 (1%) | ||
| 39 (46%) | 8 (9%) | 25 (29%) | 14 (16%) | 47 (55%) | 0 (0%) | 39 (45%) | 0 (0%) | ||
Fig 1The proportion of pediatric patients with allergic symptoms accompanied by allergen-specific IgE or IgG4 response.
Immunoglobulin response was considered to be present in cases of increased concentration of sIgE (≥0.35 IU/ml) or a significant level of sIgG4 (≥110 ng/ml) to allergens.
Fig 2Comparison of sensitization rates from different studies.
The proportion of samples with sIgE-increased concentration to each of the 31 allergens for children aged 0 to 17 years according to our data in comparison with the data of other studies conducted in the Netherlands [19] and Taiwan [20].
Fig 3Age-dependent changes in the proportion of patients with increased concentrations of sIgE.
Fig 4Age-dependent changes in the proportion of patients with significant concentrations of sIgG4.